For example, reduced intratumoural macrophage recruitment accompanied by a normalising effect on the increased levels of circulating monocyte was shown in tumour model experiments (pancreatic and colon cancer) after anti-PlGF treatment, but not after anti-VEGFR-2 therapy (Fischer et al, 2007). This evidence concerns the gene PGF and malignant colon neoplasm.